{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:48:43Z","timestamp":1789710523620,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T00:00:00Z","timestamp":1530835200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Innovative Medicine Initiative","award":["115372"],"award-info":[{"award-number":["115372"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13195-018-0396-5","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T10:42:12Z","timestamp":1530873732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics"],"prefix":"10.1186","volume":"10","author":[{"given":"Isabelle","family":"Bos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Scheltens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan","family":"Engelborghs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Frisoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Molinuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Wallin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Lle\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Popp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Martinez-Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Baird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Legido-Quigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristel","family":"Sleegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Van Broeckhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bertram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"ten Kate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Barkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Lovestone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Streffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter Jelle","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,6]]},"reference":[{"issue":"2","key":"396_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack","year":"2013","unstructured":"Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12(2):207\u201316.","journal-title":"Lancet Neurol"},{"issue":"9","key":"396_CR2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med. 2012;367(9):795\u2013804.","journal-title":"N Engl J Med"},{"issue":"3","key":"396_CR3","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.neuron.2014.10.038","volume":"84","author":"R Sperling","year":"2014","unstructured":"Sperling R, Mormino E, Johnson K. The evolution of preclinical Alzheimer's disease: implications for prevention trials. Neuron. 2014;84(3):608\u201322.","journal-title":"Neuron"},{"issue":"4","key":"396_CR4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.dadm.2015.09.001","volume":"1","author":"N Mattsson","year":"2015","unstructured":"Mattsson N, Carrillo MC, Dean RA, Devous MD Sr, Nikolcheva T, Pesini P, Salter H, Potter WZ, Sperling RS, Bateman RJ, et al. Revolutionizing Alzheimer's disease and clinical trials through biomarkers. Alzheimers Dement (Amst). 2015;1(4):412\u20139.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"7","key":"396_CR5","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nrd3115","volume":"9","author":"H Hampel","year":"2010","unstructured":"Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, Herholz K, Bokde AL, Jessen F, Hoessler YC, et al. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov. 2010;9(7):560\u201374.","journal-title":"Nat Rev Drug Discov"},{"key":"396_CR6","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.nicl.2013.03.014","volume":"2","author":"R Vandenberghe","year":"2013","unstructured":"Vandenberghe R, Adamczuk K, Dupont P, Laere KV, Chetelat G. Amyloid PET in clinical practice: its place in the multidimensional space of Alzheimer's disease. Neuroimage Clin. 2013;2:497\u2013511.","journal-title":"Neuroimage Clin"},{"issue":"10043","key":"396_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM. Alzheimer's disease. Lancet. 2016;388(10043):505\u201317.","journal-title":"Lancet"},{"issue":"5","key":"396_CR8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jalz.2014.05.1753","volume":"11","author":"FH Duits","year":"2015","unstructured":"Duits FH, Prins ND, Lemstra AW, Pijnenburg YA, Bouwman FH, Teunissen CE, Scheltens P, van der Flier WM. Diagnostic impact of CSF biomarkers for Alzheimer's disease in a tertiary memory clinic. Alzheimers Dement. 2015;11(5):523\u201332.","journal-title":"Alzheimers Dement"},{"key":"396_CR9","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.neuroimage.2017.03.057","volume":"155","author":"S Rathore","year":"2017","unstructured":"Rathore S, Habes M, Iftikhar MA, Shacklett A, Davatzikos C. A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages. NeuroImage. 2017;155:530\u201348.","journal-title":"NeuroImage"},{"issue":"1","key":"396_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1001\/2013.jamaneurol.67","volume":"70","author":"C Laske","year":"2013","unstructured":"Laske C. Blood-based biomarkers in Alzheimer disease: where are we now and where have we to go? JAMA Neurol. 2013;70(1):133.","journal-title":"JAMA Neurol"},{"issue":"1","key":"396_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jalz.2013.10.007","volume":"10","author":"HM Snyder","year":"2014","unstructured":"Snyder HM, Carrillo MC, Grodstein F, Henriksen K, Jeromin A, Lovestone S, Mielke MM, O'Bryant S, Sarasa M, Sjogren M, et al. Developing novel blood-based biomarkers for Alzheimer's disease. Alzheimers Dement. 2014;10(1):109\u201314.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"396_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/alzrt164","volume":"5","author":"D Galasko","year":"2013","unstructured":"Galasko D, Golde TE. Biomarkers for Alzheimer's disease in plasma, serum and blood\u2014conceptual and practical problems. Alzheimers Res Ther. 2013;5(2):10.","journal-title":"Alzheimers Res Ther"},{"key":"396_CR13","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fneur.2015.00236","volume":"6","author":"AL Baird","year":"2015","unstructured":"Baird AL, Westwood S, Lovestone S. Blood-based proteomic biomarkers of Alzheimer's disease pathology. Front Neurol. 2015;6:236.","journal-title":"Front Neurol"},{"issue":"3","key":"396_CR14","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3233\/JAD-170564","volume":"60","author":"BLR Reijs","year":"2017","unstructured":"Reijs BLR, Ramakers I, Elias-Sonnenschein L, Teunissen CE, Koel-Simmelink M, Tsolaki M, Wahlund LO, Waldemar G, Hausner L, Johannsen P, et al. Relation of odor identification with Alzheimer's disease markers in cerebrospinal fluid and cognition. J Alzheimers Dis. 2017;60(3):1025\u201334.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"396_CR15","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/joim.12482","volume":"279","author":"S Galluzzi","year":"2016","unstructured":"Galluzzi S, Marizzoni M, Babiloni C, Albani D, Antelmi L, Bagnoli C, Bartres-Faz D, Cordone S, Didic M, Farotti L, et al. Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study. J Intern Med. 2016;279(6):576\u201391.","journal-title":"J Intern Med"},{"issue":"4","key":"396_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000135644","volume":"30","author":"PJ Visser","year":"2008","unstructured":"Visser PJ, Verhey FR, Boada M, Bullock R, De Deyn PP, Frisoni GB, Frolich L, Hampel H, Jolles J, Jones R, et al. Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA study. Neuroepidemiology. 2008;30(4):254\u201365.","journal-title":"Neuroepidemiology"},{"issue":"1","key":"396_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3233\/JAD-151097","volume":"54","author":"C Somers","year":"2016","unstructured":"Somers C, Struyfs H, Goossens J, Niemantsverdriet E, Luyckx J, De Roeck N, De Roeck E, De Vil B, Cras P, Martin JJ, et al. A decade of cerebrospinal fluid biomarkers for Alzheimer's disease in Belgium. J Alzheimers Dis. 2016;54(1):383\u201395.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"396_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3233\/JAD-132306","volume":"41","author":"WM van der Flier","year":"2014","unstructured":"van der Flier WM, Pijnenburg YA, Prins N, Lemstra AW, Bouwman FH, Teunissen CE, van Berckel BN, Stam CJ, Barkhof F, Visser PJ, et al. Optimizing patient care and research: the Amsterdam Dementia Cohort. J Alzheimers Dis. 2014;41(1):313\u201327.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"396_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3233\/JAD-140240","volume":"42","author":"D Alcolea","year":"2014","unstructured":"Alcolea D, Carmona-Iragui M, Suarez-Calvet M, Sanchez-Saudinos MB, Sala I, Anton-Aguirre S, Blesa R, Clarimon J, Fortea J, Lleo A. Relationship between beta-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease. J Alzheimers Dis. 2014;42(1):157\u201367.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"396_CR20","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3233\/JAD-2010-100678","volume":"22","author":"J Fortea","year":"2010","unstructured":"Fortea J, Sala-Llonch R, Bartres-Faz D, Bosch B, Llado A, Bargallo N, Molinuevo JL, Sanchez-Valle R. Increased cortical thickness and caudate volume precede atrophy in PSEN1 mutation carriers. J Alzheimers Dis. 2010;22(3):909\u201322.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"396_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00259-015-3156-9","volume":"43","author":"K Adamczuk","year":"2016","unstructured":"Adamczuk K, Schaeverbeke J, Nelissen N, Neyens V, Vandenbulcke M, Goffin K, Lilja J, Hilven K, Dupont P, Van Laere K, et al. Amyloid imaging in cognitively normal older adults: comparison between (18)F-flutemetamol and (11)C-Pittsburgh compound B. Eur J Nucl Med Mol Imaging. 2016;43(1):142\u201351.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"396_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.neurobiolaging.2016.10.013","volume":"50","author":"A Estanga","year":"2017","unstructured":"Estanga A, Ecay-Torres M, Ibanez A, Izagirre A, Villanua J, Garcia-Sebastian M, Iglesias Gaspar MT, Otaegui-Arrazola A, Iriondo A, Clerigue M, et al. Beneficial effect of bilingualism on Alzheimer's disease CSF biomarkers and cognition. Neurobiol Aging. 2017;50:144\u201351.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"396_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/jcbfm.2015.148","volume":"36","author":"A Wallin","year":"2016","unstructured":"Wallin A, Nordlund A, Jonsson M, Blennow K, Zetterberg H, Ohrfelt A, Stalhammar J, Eckerstrom M, Carlsson M, Olsson E, et al. Alzheimer's disease\u2014subcortical vascular disease spectrum in a hospital-based setting: overview of results from the Gothenburg MCI and dementia studies. J Cereb Blood Flow Metab. 2016;36(1):95\u2013113.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"396_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13195-017-0235-0","volume":"9","author":"D Tautvydaite","year":"2017","unstructured":"Tautvydaite D, Kukreja D, Antonietti JP, Henry H, von Gunten A, Popp J. Interaction between personality traits and cerebrospinal fluid biomarkers of Alzheimer's disease pathology modulates cognitive performance. Alzheimers Res Ther. 2017;9(1):6.","journal-title":"Alzheimers Res Ther"},{"issue":"11","key":"396_CR25","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412\u20134.","journal-title":"Neurology"},{"issue":"9","key":"396_CR26","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","volume":"139","author":"B Reisberg","year":"1982","unstructured":"Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139(9):1136\u20139.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"396_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","volume":"256","author":"RC Petersen","year":"2004","unstructured":"Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183\u201394.","journal-title":"J Intern Med"},{"issue":"3","key":"396_CR28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","volume":"256","author":"B Winblad","year":"2004","unstructured":"Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, et al. Mild cognitive impairment\u2014beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256(3):240\u20136.","journal-title":"J Intern Med"},{"issue":"7","key":"396_CR29","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34(7):939\u201344.","journal-title":"Neurology"},{"key":"396_CR30","first-page":"96","volume":"2014","author":"E Scheufele","year":"2014","unstructured":"Scheufele E, Aronzon D, Coopersmith R, McDuffie MT, Kapoor M, Uhrich CA, Avitabile JE, Liu J, Housman D, Palchuk MB. tranSMART: an open source knowledge management and high content data analytics platform. AMIA Jt Summits Transl Sci Proc. 2014;2014:96\u2013101.","journal-title":"AMIA Jt Summits Transl Sci Proc"},{"issue":"6","key":"396_CR31","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jalz.2014.05.1749","volume":"10","author":"A Hye","year":"2014","unstructured":"Hye A, Riddoch-Contreras J, Baird AL, Ashton NJ, Bazenet C, Leung R, Westman E, Simmons A, Dobson R, Sattlecker M, et al. Plasma proteins predict conversion to dementia from prodromal disease. Alzheimers Dement. 2014;10(6):799\u2013807. e792","journal-title":"Alzheimers Dement"},{"issue":"10","key":"396_CR32","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","volume":"55","author":"P Scheltens","year":"1992","unstructured":"Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J. Atrophy of medial temporal lobes on MRI in \u201cprobable\u201d Alzheimer\u2019s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55(10):967\u201372.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"396_CR33","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000117270","volume":"36","author":"F Pasquier","year":"1996","unstructured":"Pasquier F, Leys D, Weerts JG, Mounier-Vehier F, Barkhof F, Scheltens P. Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol. 1996;36(5):268\u201372.","journal-title":"Eur Neurol"},{"issue":"12","key":"396_CR34","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1007\/s00330-011-2205-4","volume":"21","author":"EL Koedam","year":"2011","unstructured":"Koedam EL, Lehmann M, van der Flier WM, Scheltens P, Pijnenburg YA, Fox N, Barkhof F, Wattjes MP. Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol. 2011;21(12):2618\u201325.","journal-title":"Eur Radiol"},{"issue":"3","key":"396_CR35","first-page":"175","volume":"28","author":"A Redolfi","year":"2013","unstructured":"Redolfi A, Bosco P, Manset D, Frisoni GB. Brain investigation and brain conceptualization. Funct Neurol. 2013;28(3):175\u201390.","journal-title":"Funct Neurol"},{"issue":"4","key":"396_CR36","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.nic.2005.09.008","volume":"15","author":"SG Mueller","year":"2005","unstructured":"Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack C, Jagust W, Trojanowski JQ, Toga AW, Beckett L. The Alzheimer's Disease Neuroimaging Initiative. Neuroimaging Clin N Am. 2005;15(4):869\u201377. xi\u2013xii.","journal-title":"Neuroimaging Clin N Am"},{"issue":"4","key":"396_CR37","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1017\/S1041610209009405","volume":"21","author":"KA Ellis","year":"2009","unstructured":"Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, Lautenschlager NT, Lenzo N, Martins RN, Maruff P, et al. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Int Psychogeriatr. 2009;21(4):672\u201387.","journal-title":"Int Psychogeriatr"},{"issue":"7266","key":"396_CR38","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature08538","volume":"461","author":"RJ Perrin","year":"2009","unstructured":"Perrin RJ, Fagan AM, Holtzman DM. Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature. 2009;461(7266):916\u201322.","journal-title":"Nature"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-018-0396-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-018-0396-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-018-0396-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T02:06:22Z","timestamp":1604541982000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-018-0396-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,6]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["396"],"URL":"https:\/\/doi.org\/10.1186\/s13195-018-0396-5","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,6]]},"assertion":[{"value":"10 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from all participants before inclusion in the study. The medical ethics committee at each site approved the study (Additional file\n                      \n                      : Table S4).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"64"}}